North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.
复制标题

DOI:
10.1016/j.jaad.2019.02.067
复制
发表时间:
2019-07
影响因子:
13.8
通讯作者:
Poulin, Yves
Poulin, Yves
中科院分区:
医学1区
文献类型:
--
作者:
Alikhan, Ali;Sayed, Christopher;Alavi, Afsaneh;Alhusayen, Raed;Brassard, Alain;Burkhart, Craig;Crowell, Karen;Eisen, Daniel B.;Gottlieb, Alice B.;Hamzavi, Iltefat;Hazen, Paul G.;Jaleel, Tara;Kimball, Alexa B.;Kirby, Joslyn;Lowes, Michelle A.;Micheletti, Robert;Miller, Angela;Naik, Haley B.;Orgill, Dennis;Poulin, Yves

文献摘要

参考文献

被引文献

相似文献

化脓性汗腺炎是一种影响毛囊的慢性炎症性疾病,对患者的生活质量产生深远的负面影响。在许多地区,对化脓性汗腺炎患者进行理想评估和治疗的证据仍然很少,但在过去十年中已经大幅增长。本循证指南的第一部分旨在支持医疗保健从业者选择最佳管理策略,包括诊断测试、合并症筛查以及补充和程序治疗方案。提供基于审查时可用证据的建议和证据分级。
Hidradenitis suppurativa is a chronic inflammatory disorder affecting hair follicles, with profoundly negative impact on patient quality of life. Evidence informing ideal evaluation and management of patients with hidradenitis suppurativa is still sparse in many areas, but it has grown substantially in the last decade. Part I of this evidence-based guideline is presented to support health care practitioners as they select optimal management strategies, including diagnostic testing, comorbidity screening, and both complementary and procedural treatment options. Recommendations and evidence grading based on the evidence available at the time of the review are provided.
DOI: 10.1111/j.1468-3083.2010.03934.x
发表时间: 2011-10-01
影响因子: 9.2
作者:
Brocard, A.;Dreno, B.
通讯作者: Dreno, B.
DOI: 10.1111/jdv.12952
发表时间: 2015-08-01
影响因子: 9.2
作者:
Blok, J. L.;Boersma, M.;Horvath, B.
通讯作者: Horvath, B.
DOI: 10.1016/j.ijwd.2017.10.007
发表时间: 2018-06
影响因子: --
作者:
Alavi A;Farzanfar D;Rogalska T;Lowes MA;Chavoshi S
通讯作者: Chavoshi S
DOI: 10.1111/j.1524-4725.2007.34042.x
发表时间: 2008-02-01
影响因子: 2.4
作者:
Aksakal, A. Burhan;Adisen, Esra
通讯作者: Adisen, Esra
DOI: 10.1186/1471-5945-12-9
发表时间: 2012-06-26
期刊: BMC dermatology
影响因子: --
作者:
Alharbi Z;Kauczok J;Pallua N
通讯作者: Pallua N